Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20366 (
substance P
)
21,176
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The action of
substance P
(SP) on mucosal ion transport has been investigated in the guinea-pig small intestine. Segments of intestine were dissected free of external muscle and myenteric plexus and mounted in Ussing chambers. Short-circuit current (Isc) was measured as an indication of net ion transport across the tissue. SP (greater than 10(-10) M) added to the submucosal side of the tissue caused a transient increase in Isc. Tetrodotoxin (TTX, 10(-7) M) decreased the maximum SP response to 11% of the control value. TTX completely inhibited the response to electrical field stimulation but had no effect on Isc increases due to carbachol or theophylline. In the presence of hyoscine (10(-7) M) the SP response was reduced to 42% of the control value, but hyoscine had no effect on the TTX-resistant SP response.
Mepyramine
(10(-6)M) had no significant effect on the SP response. These results suggest that SP alters mucosal ion transport by stimulation of cholinergic and non-cholinergic nerves in the mucosa-submucosa. A small part of the SP response appears to be due to a direct action on epithelial cells. The SP antagonist (D-Arg1, D-Pro2, D-Trp7,9, Leu11)-SP decreased the magnitude of the TTX-resistant SP response, and caused a decrease of similar magnitude in the total SP response. These results imply that the major component of the SP response, which is due to an action on neurons, is unaffected by this antagonist. It is concluded that the SP receptors on epithelial cells are blocked by the antagonist and are different to the SP receptors on submucous neurons, which are not blocked by the antagonist.
...
PMID:Different substance P receptors are found on mucosal epithelial cells and submucous neurons of the guinea-pig small intestine. 241 39
We examined the effects of the neuropeptide
substance P
on pulmonary hemodynamic and transvascular fluid filtration in isolated Ringer's-perfused and blood-enriched Ringer's-perfused guinea pig lung and on albumin flux across bovine pulmonary artery endothelial monolayer. Mean pulmonary artery, left atrial, and capillary pressures were determined and used to calculate arterial and venous resistances, and lung weight was continuously monitored.
Substance P
(0.01-1.0 microM) caused marked increases in pulmonary arterial pressure, capillary pressure, venous resistance, and lung weight within 3-5 minutes after administration. These responses remained elevated above baseline at the end of the 30-minute experimental period in the Ringer's-perfused lungs but not in the blood-enriched Ringer's-perfused lungs.
Substance P
did not alter the capillary filtration coefficient in isolated lungs and transendothelial albumin permeability in the endothelial monolayer.
Substance P
resulted in an increase in venous effluent thromboxane B2 concentrations in perfused lungs but had no effect on 6-keto-prostaglandin F1 alpha concentrations. Papaverine (0.27 mM) (a smooth-muscle relaxant) abolished the pulmonary microvascular response to
substance P
in Ringer's-perfused lungs, and meclofenamate (0.15 mM) (a cyclooxygenase inhibitor) attenuated the pulmonary vasoconstriction and lung weight increase.
Pyrilamine
(1.0 microM) (a histamine1-receptor antagonist) did not alter the responses to
substance P
. In conclusion,
substance P
does not affect pulmonary vascular permeability to water and protein.
Substance P
induces an intense pulmonary vasoconstriction (due to greater constriction of postcapillary vessels) and an elevation in pulmonary capillary pressure that increases net transvascular fluid filtration.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Substance P-induced pulmonary vasoreactivity in isolated perfused guinea pig lung. 244 56
Using an electromyographic technique, an ascending excitatory response was recorded "in vitro" in the presence of atropine in the cat small intestine up to 70 mm orally with respect to the site of repetitive transmural nerve stimulation. This non-cholinergic ascending excitatory response was characterized by an increase in the slow wave amplitude and spiking activity. This response was reversibly abolished by Tetrodotoxin (3,1 X 10(-6) M) but remained unchanged after exposure of the intestine to: Hexamethonium (4,9 X 10(-6) M) plus Tubocurarine (1,4 X 10(-5) M), Guanethidine (5 X 10(-7) to 5 X 10(-5) M), Domperidone (2,3 X 10(-7) to 2,3 X 10(-5) M), Naloxone (3 X 10(-7) to 3 X 10(-5) M), Methysergide (2,8 X 10(-7) to 2,8 X 10(-5) M), Metergoline (2,4 X 10(-5) M), Methiotepin (2,1 X 10(-5) M) and
Mepyramine
(2,3 X 10(-5) M). This response was unaffected by the
substance P
analogues, D-Pro2, D-Phe7, D-Trp9-
Substance P
(10(-5) M) or D-Pro2, D-Trp7-9-
Substance P
(10(-5) M) but was reversibly abolished after exposure of the intestine to
substance P
(10(-6) M). Moreover
substance P
still effectively abolished this response in the presence of any two of the above analogues. The results of the present study show that the non-cholinergic excitatory response elicited in the cat small intestine due to the activity of long ascending pathways probably involved
substance P
. The functional significance of this response is discussed.
...
PMID:Non-cholinergic ascending excitatory response in the cat small intestine: possible involvement of substance P. 246 25
The actions of histamine on myenteric neurones were investigated with intracellular recording methods in guinea-pig small intestine. The actions of histamine at the ganglion cell soma were: membrane depolarization, increased input resistance, suppression of post-spike hyperpolarizing potentials, augmented excitability and repetitive spike discharge. Excitability was enhanced also at spike initiation sites remote from the cell body. Both H1, and H2, receptors were involved in the response to histamine. Dimaprit mimicked the responses to histamine in 80% and 2-methylhistamine in 50% of the trials. Cimetidine was an antagonist for histamine in 82% and for dimaprit in all of the trials.
Pyrilamine
blocked the actions of histamine in 59% of the cells and always blocked the action of 2-methylhistamine. Histamine mimicked slow synaptic excitation in the neurones, but was ruled out as a neurotransmitter for the slow excitatory post-synaptic potential (e.p.s.p.). Histamine either did not affect the responses to 5-hydroxytryptamine,
substance P
and acetylcholine or it potentiated the responses to these putative neurotransmitters for slow synaptic excitation. The results support the possibility that histamine released from mast cells by circulating peptidergic messengers, by neurotransmitters or during anaphylaxis could influence enteric nervous function.
...
PMID:Intracellular study of effects of histamine on electrical behaviour of myenteric neurones in guinea-pig small intestine. 614 13
Dimaprit, a highly selective H2-agonist, caused a multiphasic contraction of guinea-pig ileal segments and ileal myenteric plexus-longitudinal muscle preparations. The initial phase was characterized by a twitch which reached a maximum in 15 to 30 sec and was followed by a partial relaxation. The later phase was variable and consisted of a series of twitch responses or of a slowly developing contracture which sometimes was accompanied by oscillatory changes in tension. dose-response curves were generated for the initial response; for isolated ileal segments the EC50 was 5.1 +/- 1.8 micrometers (mean +/- S.D., N = 7) and the Hill coefficient was 1.1 +/- 0.2 and for longitudinal muscle strips the EC50 was 5.8 +/- 1.2 micrometer and the Hill coefficient was 1.2 +/- 0.1 (N = 7). Both the initial and secondary components of the contractile responses to dimaprit were prevented by 0.2 micron tetrodotoxin or 10 microns mefenamic acid and by the production of tachphylaxis to either
substance P
or serotonin. Scopolamine, 0.001 to 0.1 micron, insurmountably antagonized only the initial component of the response.
Mepyramine
(1.0 micrometer), hexamethonium (100 microns), bromolysergic acid (0.25 microns) and p-(imidazol-1-yl)phenyl (10 microns) were without effect on the response to dimaprit. The histamine H2-receptor antagonist, tiotidine, produced parallel dextral shifts in the dose-response curve for dimaprit. The apparent pA2 value for tiotidine was 7.65. The results suggest that dimaprit acts on H2-receptors located on myenteric plexus neurons to cause the release of contractile substances. The mediators of the contractile response are tentatively identified as acetylcholine,
substance P
, serotonin and a product(s) of the arachadonic acid cascade.
...
PMID:Histamine H2-receptors on guinea-pig ileum myenteric plexus neurons mediate the release of contractile agents. 617 31
Rabbit ileal mucosa, when mounted in a flux chamber and stimulated with a 5 Hz electrical field (EFS), secretes Cl, a change reflected in an increase in short circuit current (Iac). Because the EFS response is eliminated by agents which prevent neural transmission, the mediator is most likely a neurotransmitter present in nerves lying close to the secreting epithelium. To identify the chemical mediators of the response, we determined the effects of receptor antagonists, agonist desensitization and other agents on the Isc response to EFS. Because of the failure of antagonists or desensitization to affect the response to EFS, we eliminated the following agents as possible mediators: acetylcholine (pre- and postganglionic), norepinephrine, dopamine, 5-hydroxytryptamine, histamine, prostaglandins, adenosine triphosphate, bombesin, neurotensin and
Substance P
.
Pyrilamine
, diphenhydramine and cyproheptadine in high concentration (0.1 mM) reduced markedly the Isc response to EFS for reasons unrelated to histamine antagonism. Although acetylcholine has been shown in the ileum of humans and of guinea pigs to mediate up to half of the Isc response to EFS, the identity of the mediator(s) in rabbit ileum remains unknown.
...
PMID:Electrical stimulus-secretion coupling in rabbit ileal mucosa. 620 86
Vascular permeability was significantly increased in the incisor pulp and skin of the lower lip in the rat after antidromic electrical stimulation of the inferior alveolar nerve, and this response was significantly inhibited by a substance-P antagonist. The content of
substance P
in the pulp and lip was also increased after stimulation. The permeability response was reduced by aspirin and bradykinin antagonists (both B1- and B2-receptor types) in the pulp and lip, indicating that prostaglandins and bradykinin may be involved.
Mepyramine
and methysergide inhibited the vascular response in the lip but not the pulp; the roles of histamine and serotonin differ in the two tissues. Injection of
substance P
into the incisor pulp and the lip skin caused dye leakage. This response was inhibited by pretreatment with compound 48/80 in the lip but not the pulp. Lip histamine content was decreased significantly after antidromic stimulation of the inferior alveolar nerve and pretreatment with compound 48/80, but was not changed in the pulp. The results suggest that
substance P
in the lip, after being released from the peripheral sensory-nerve endings, may act on the vascular system via histamine release from mast cells; but in the pulp may cause vascular response directly because of the scarcity of mast cells.
...
PMID:Role of substance P in neurogenic inflammation in the rat incisor pulp and the lower lip. 768 6
The effects of pituitary adenylate cyclase activating peptide (PACAP) 38, PACAP 27 and vasoactive intestinal peptide (VIP) on plasma extravasation were investigated in vivo in rat skin. PACAP 38, PACAP 27 and VIP, caused concentration-dependent extravasation in rat skin. The order of potency was PACAP 38 > PACAP 27 = VIP, whereas the order of maximal induced extravasation was PACAP 38 = PACAP 27 > VIP, suggesting that PACAP 38 might be the most powerful inducer of plasma extravasation of the three tested members of the secretin-glucagon-VIP family.
Substance P
(SP) was about 5 times more potent than PACAP 38 and 15 times more potent than PACAP 27. These data indicate that PACAP 38 induced plasma extravasation in concentrations roughly equimolar to SP.
Pyrilamine
(H1 receptor antagonist) reduced the PACAP 38-induced plasma extravasation more than 50%; cimetidine (H2 receptor antagonist) was without effect. To investigate whether a cAMP-mediated process is involved in the induction of plasma extravasation, the synthetic adenosine 3',5'-cyclic monophosphate (cAMP), dibutyryl adenosine cyclic monophosphate (DBcAMP) and the cAMP-inducing drug, salbutamol, were each injected in the skin; neither of these drugs caused extravasation. We conclude that PACAP 38 and PACAP 27 cause potent plasma extravasation which, at least in part, involves histamine release.
...
PMID:PACAP-induced plasma extravasation in rat skin. 941 88
In vitro studies were conducted to characterize the contractile effects of tachykinins in normal ovine trachea with a view in the future to compare
tachykinin
contractile responses in allergic tissue. Tracheal smooth muscle strips were prepared for in vitro studies of isometric contraction in response to cumulative addition of carbachol, acetylcholine, histamine,
neuropeptide gamma
,
substance P
,
neurokinin A
, neurokinin B, [Sar9, Met(O2)11]
substance P
, [Nle10]
neurokinin A
-(4-10), and [Succinyl-Asp6, Me-Phe8]
substance P
-(6-11) (senktide). The rank order of potency was
neuropeptide gamma
> carbachol >
neurokinin A
> or = [Nle10]
neurokinin A
-(4-10) > acetylcholine > or = histamine. Phosphoramidon enhanced the contractile response to
neurokinin A
and
substance P
, but not to
neuropeptide gamma
, [Sar9, Met(O2)11]
substance P
or senktide. Repeated cumulative concentration responses for acetylcholine,
substance P
,
neurokinin A
, [Sar9, Met(O2)11]
substance P
and histamine were also conducted to test for tachyphylaxis. No tachyphylaxis to acetylcholine,
substance P
, or
neurokinin A
was observed, however, [Sar9, Met(O2)11]
substance P
and histamine did exhibit tachyphylaxis. Atropine had no effect on tracheal contractions to
neurokinin A
and
substance P
, while [Sar9, Met(O2)11]
substance P
contractions were atropine sensitive.
Pyrilamine
did not affect
substance P
-induced tracheal smooth muscle contractions, indicating that the response to
substance P
was not mediated by histamine release. These results show that, in vitro, natural tachykinins induce tracheal smooth muscle contraction predominantly by a direct effect mediated by
tachykinin
NK2 receptors, and a small
tachykinin
NK1 receptor mediated cholinergic mechanism.
...
PMID:Tachykinin NK2 receptors predominantly mediate tachykinin-induced contractions in ovine trachea. 954 42
Intrathecal injection of histamine elicited behavioral responses consisting of scratching, biting and licking in conscious mice. To study the participation of histamine in pain perception, histidine decarboxylase knockout mice were examined for pain threshold by means of three different kinds of noxious stimuli: thermal nociception (hot-plate, tail-flick, and paw-withdrawal), mechanical nociception (tail-pressure), and chemical nociception (formalin test and capsaicin test). Mutant mice lacking histidine decarboxylase showed significantly fewer nociceptive responses to the hot-plate, tail-flick, paw-withdrawal, tail-pressure, formalin and capsaicin tests. Sensitivity to noxious stimuli in the histidine decarboxylase knockout mice was significantly lower when compared to the wild-type mice. The intrathecally-administered histamine (400 pmol) significantly shortened the latency in the histidine decarboxylase knockout mice, but not in the wild-type mice in tail-flick tests.
Pyrilamine
, a histamine H(1) receptor antagonist, but not ranitidine, a histamine H(2) receptor antagonist, produced inhibition of the induced behavioral responses in the tail-flick test when co-administered with histamine. Sendide, a
tachykinin
NK(1) receptor antagonist, inhibited histamine-induced nociceptive behavior in the histidine decarboxylase knockout mice. In contrast, the treatment with D-(-)-2 amino-5-phosponovaleric acid (D-APV), an N-methyl-D-aspartate (NMDA) receptor antagonist, did not prevent the induction of the behavioral responses by histamine. These studies substantiate the evidence that nociceptive behavior induced by intrathecal injection of histamine is largely mediated through
tachykinin
NK(1) and histamine H(1) receptors in the spinal cord.
...
PMID:Intrathecally-administered histamine facilitates nociception through tachykinin NK1 and histamine H1 receptors: a study in histidine decarboxylase gene knockout mice. 1621 54
1
2
Next >>